Entrepreneur-in-Residence (EIR) Program

CTTC’s Entrepreneur-in-Residence (EIR) program brings experienced businesspeople to Vanderbilt to advise and assist faculty and staff as they launch startups and explore the commercialization of research. EIRs are experts in business formation and operations who have been successful entrepreneurs, investors in startup companies, and seasoned executives from large corporations with experience in an entrepreneurial setting. EIRs offer entrepreneurs valuable industry connections and expertise.

EIRs conduct a variety of activities. They evaluate technologies for their appropriateness as the basis for a startup company. They develop business plans, financial models, go-to-market strategies, and the like. They advise on management teams, advisory boards, and corporate governance. They mentor Vanderbilt researchers who are exploring potential startup opportunities. They connect these startups to investors and potential strategic partners.

To learn more about becoming an EIR, contact 

Entrepreneurs In Residence

Evaluating, advising, and engaging with startup companies commercializing innovations from Vanderbilt inventors and creators

Gerry Barañano, MBA

Entrepreneur in Residence
A highly effective and experience mentor, Gerry Barañano personally guided 40+ companies to raise over $100 million in equity and grants. Gerry brings a comprehensive understanding of all elements necessary to start a successful technology company. Gerry prepares tech startups for equity and grant fund raising, helps them craft successful go-to-market strategies and guides them to get their first paying customers. Gerry served as a mentor to an NSF I-Corps team from UC Berkeley and also an entrepreneurial team from LLNL in the DOE Energy I-Corps program. Gerry holds an MBA from Stanford University and an undergraduate degree from Yale University.

Andrew Goldner

CEO & Founding Partner, Growthx

Andrew has been in the startup scene since 1998, based in NYC, Hong Kong, Singapore, Palo Alto and Nashville. He kicked off his career when the Internet was first commercializing as a tech lawyer for Alta Vista, Yahoo, DoubleClick, Salesforce and others pioneers. When Google acquired DoubleClick, Andrew co-founded a financial news business for the Thomson family and when they acquired Reuters (and became Thomson Reuters), Andrew became Publisher of Reuters News.

Andrew returned to America and early-stage tech in 2012 and then co-founded GrowthX, an early-stage VC fund run by go-to-market experts. GrowthX sequenced the path to product-market fit to help their founders reduce the time it takes to get investment-ready for their Series A, and retain more ownership along their journey.

 

Areas of Expertise / Interest:   

Venture Capital, Go-to-Market, Product-Market Fit, Customer Discovery, Market Development

Adam Jay Harrison

Entrepreneur in Residence
Adam Jay Harrison is an entrepreneur, inventor, and senior executive who has worked extensively with the US Department of Defense and national security community on topics related to technological innovation and competitiveness. He has founded and led multiple technology startups in the aerospace and defense sector and currently manages a boutique venture capital fund, Dead Run Ventures. Jay is the John R. Boyd National Security Innovation Fellow at New York University, where he researches the efficacy of national innovation policies that capitalize on collaboration between the Federal government, universities, and the private sector.

Jim Monsor

CEO, Relay Life Science

Jim has more than 33 years of device, diagnostic, drug, and biologics experience.

He is currently CEO of Relay Life Science. Most recently he served as COO for BioMimetic Therapeutics for 12  years; leading growth from four to 100 employees.

He has broad experience in commercial operations, supply chain management, product development, tech transfer, quality, regulatory, IT, and facilities management for drug, device, biologics, combination products, and bulk drug products. His experience spans early stage research through all phases of development, product launch, and routine commercial operations. Jim is also head of the LifeScienceTN Mentor program and a member of NueCura, an angel investment network in Brentwood, TN.

Brian Moyer

Entrepreneur in Residence

Brian is a tech entrepreneur, founder, board member and advisor.  He is listed on the Nashville Business Journal’s 2020 and 2021 Power 100 list of most influential business leaders in Nashville and ranked #5 on the @RiseGlobal Top 100 Thought Leaders in IT. 
 
Brian studied Economics and Engineering Management at the Missouri University of Science and Technology before leaving to launch his first startup.  He is a Certified Professional in Healthcare Information & Management Systems and is a HIMSS Fellow. 

Joshua Trantum, Ph.D.

President, Principal, Chief Investment Officer

Josh is currently the President and Chief Investment Officer of CUREX Capital Advisors, a Nashville, TN-based firm investing in publicly traded life science companies. Josh has spent his career in the life science industry in senior leadership roles of operating companies as well as on the investment side in equity research and portfolio management. Earlier in his career, Josh developed and commercialized multiple Class III medical devices, co-founded an immuno-oncology diagnostic company, and managed pre-clinical drug development activities for a NASDAQ-listed biopharmaceutical company.  Josh earned his MBA from Emory University and his doctorate degree from Vanderbilt University in the Department of Biomedical Engineering where he currently holds an adjunct appointment as Assistant Professor.

 

Areas of Expertise / Interest:   

Medical devices, biotechnology, business strategy, technology transfer, venture funding